Free Trial

Grace Therapeutics (GRCE) SEC Filings & 10K Form

Grace Therapeutics logo
$2.99 -0.08 (-2.61%)
As of 08/28/2025 04:00 PM Eastern

Recent Grace Therapeutics SEC Filings

DateFilerForm TypeView
08/27/2025
7:08 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2025
7:00 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2025
6:31 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/28/2025
6:00 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form DEF 14A
07/28/2025
6:01 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form DEFA14A
06/25/2025
7:19 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
7:00 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
6:43 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
05/15/2025
6:33 PM
ADAR1 Capital Management, LLC (Filed by)
Grace Therapeutics, Inc. (Subject)
Grace Therapeutics (Subject)
Form SCHEDULE 13G/A
05/08/2025
6:51 AM
Grace Therapeutics, Inc. (Subject)
Grace Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
Form SCHEDULE 13G/A
04/16/2025
7:58 PM
D'Andrea Carrie (Reporting)
Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:58 PM
Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Kohli Prashant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:58 PM
DelAversano Robert J (Reporting)
Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:58 PM
Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Macdonald R. Loch (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
7:58 PM
Grace Therapeutics, Inc. (Issuer)
Grace Therapeutics (Issuer)
Kumar Amresh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
7:00 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
11:15 PM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form EFFECT
03/10/2025
6:58 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/03/2025
7:00 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
2:05 PM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
02/18/2025
7:25 PM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 10-Q/A
02/13/2025
7:00 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
6:30 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/10/2025
7:11 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
5:13 AM
Grace Therapeutics, Inc. (Subject)
Grace Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
Form SCHEDULE 13G/A
11/14/2024
10:58 AM
BANK OF AMERICA CORP /DE/ (Filed by)
Grace Therapeutics, Inc. (Subject)
Grace Therapeutics (Subject)
Form SC 13G/A
11/13/2024
7:00 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
6:30 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2024
7:22 AM
Grace Therapeutics, Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
7:13 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
11:15 PM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form EFFECT
10/15/2024
11:15 PM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form EFFECT
10/08/2024
6:22 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/08/2024
6:13 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form POS AM
10/08/2024
6:15 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form POS AM
10/08/2024
6:16 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-8 POS
10/08/2024
6:16 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-8 POS
10/08/2024
6:16 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form S-8 POS
09/30/2024
3:31 PM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
7:00 AM
Acasti Pharma Inc. (Filer)
Grace Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GRCE) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners